Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful
Keraliya, Abhishek R.
Tirumani, Sree Harsha
Lele, Vikram R.
MetadataShow full item record
CitationShah, Hina J., Abhishek R. Keraliya, Jyothi P. Jagannathan, Sree Harsha Tirumani, Vikram R. Lele, and Pamela J. DiPiro. 2017. “Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful.” Korean Journal of Radiology 18 (1): 54-70. doi:10.3348/kjr.2017.18.1.54. http://dx.doi.org/10.3348/kjr.2017.18.1.54.
AbstractDiffuse large B cell lymphoma (DLBCL) is the most common histological subtype of Non-Hodgkin's lymphoma. As treatments continues to evolve, so do imaging strategies, and positron emission tomography (PET) has emerged as the most important imaging tool to guide oncologists in the diagnosis, staging, response assessment, relapse/recurrence detection,and therapeutic decision making of DLBCL. Other imaging modalities including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and conventional radiography are also used in the evaluation of lymphoma. MRI is useful for nervous system and musculoskeletal system involvement and is emerging as a radiation free alternative to PET/CT. This article provides a comprehensive review of both the functional and morphological imaging modalities, available in the management of DLBCL.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:30371025
- HMS Scholarly Articles